Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation.

S. Joeres,Florian M.A. Heussen,Tobias Treziak,S. Bopp,Antonia M. Joussen

Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation.

2007

S. Joeres
Florian M.A. Heussen
Tobias Treziak
S. Bopp
Antonia M. Joussen

Aim To determine the anatomical and functional outcome after injection of bevacizumab (Avastin, Genentech) in eyes with retinal angiomatous proliferation (RAP).

Keywords:

Bevacizumab
Cardiology
Anatomy
Retinal
Visual acuity
Internal medicine
Adverse effect
Medicine
Surgery
in patient
Diabetes mellitus
Ophthalmology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations